PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.\', \'Universidad Santo Tomás, Bogotá, Colombia.\', \'Grupo Inmunovirología, Universidad de Antioquia, Medellín, Colombia.\', \'Department of NMR Based Structural Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.\', \'Universidad de Ciencias Aplicadas y Ambientales (U.D.C.A), Bogotá, Colombia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.724060
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34539660
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • The First Chemically-Synthesised, Highly Immunogenic Anti-SARS-CoV-2 Peptides in DNA Genotyped Aotus Monkeys for Human Use.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all